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Abstract
Intestinal immune regulation including development of oral tolerance is of great importance for the maintenance
of intestinal homeostasis. Concerning this, regulatory T cells (Tregs) occupy a pivotal role in cell-mediated
immunosuppression. Dysregulation of mucosal immunology leading to an abnormal interaction with commensal
bacteria is suggested to play a key role in the pathogenesis of Inflammatory Bowel Disease (IBD) in men and dogs.
The aim of this study was to characterise the expression of Foxp3 in the normal canine gut of 18 dogs (mean age:
6.03 years), in 16 dogs suffering from IBD (mean age: 5.05 years), and of 6 dogs with intestinal nematode infection
(mean age: 0.87 years) using immunohistochemistry. In the duodenum, Tregs in healthy dogs declined from villi
(median: 10.67/62 500 μm
2) to crypts (median: 1.89/62 500 μm
2). Tregs were further increased in the villi of middle-
aged dogs (median: 18.92/62 500 μm
2) in contrast to juvenile (median: 3.50/62 500 μm
2) and old (median: 9.56/62
500 μm
2) individuals. Compared to healthy controls, animals suffering from IBD revealed reduced numbers of Tregs
in duodenal villi (median: 4.13/62 500 μm
2). Dogs with intestinal nematode infection displayed increased numbers
of Tregs (median: 21.06/62 500 μm
2) compared to healthy animals.
Age-related changes indicate a progressive establishment of oral tolerance and immunosenescence in the canine
elderly. The results further suggest that a defect in Treg homeostasis may be involved in the pathogenesis of
canine IBD. In contrast, increased numbers of Tregs in the duodenum may be due to nematode infection.
Introduction
The vertebrate’s gut is perpetually exposed to an enor-
mous amount of different microorganisms and food
proteins with antigenic properties that are essential for
the individual’s life. Concerning this high antigenic load,
a complex immunological network has been developed
representing an effective protection composed of more
structured areas (lymphoid aggregates, Peyer’s patches,
lymphoglandular complexes, and mesenteric lymph
nodes) as well as diffuse parts (lamina propria leucocytes
and intraepithelial lymphocytes) [1-4]. Due to the intest-
inal colocalisation of commensal bacteria and pathogens,
mechanisms preventing specific immune responses
against orally administrated antigens (e.g. food proteins
and commensal bacteria) termed as oral tolerance are as
much as essential as the induction of specific immune
responses against pathogenic organisms.
In general, immune regulation can be either mediated by
regulatory cytokines (e.g. tissue growth factor (TGF)-b,
interleukin (IL)-10) or cellular interactions. Today, it is
well-known that specialised T helper cells with regulatory
properties (Tregs) play an important part in immune regu-
lation [5,6]. Depletion of these cells or mutations of related
transcription factors provokes severe cases of autoimmune
diseases and chronic inflammatory disorders as described
in rats, mice, and men [7-10]. Furthermore, oral tolerance
is supposed to be mainly mediated by the induction and
expansion of Tregs in the context of specialised tolero-
genic dendritic cells in the gut [11-13]. Alongside their
regulatory capacity, Tregs are characterised by the expres-
sion of CD4, CD25 [7], and the highly conserved tran-
scription factor Forkhead box P3 (Foxp3) [14] serving a
pivotal role in stabilising their regulatory properties [15].
Canine idiopathic Inflammatory Bowel Disease (IBD)
is a term used for a variety of disorders characterised by
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(e.g. vomiting, diarrhoea, and weight loss) with no
underlying cause (e.g. parasitosis, bacterial infection,
food allergy, lymphoma, or lymphangiectasia) and histo-
logical evidence of mucosal inflammatory infiltration
[16-18].
In humans, idiopathic IBD is known as Crohn’s disease
(CD) or ulcerative colitis (UC) [19,20]. CD is characterised
by transmural neutrophilic inflammation followed by
granuloma formation commonly present in the terminal
jejunum and ileum and is often complicated by intestinal
or anal fistulae, strictures, obstructions, or intestinal per-
forations [21]. In UC, neutrophilic infiltration is restricted
to the colonic and rectal mucosa and is associated with
ulceration and crypt abscesses. In addition to intestinal
lesions, extraintestinal manifestations (e.g. arthritis, renal
disease, pyrexia, mucocutaneous lesions, hepatobiliary
complications, or osteopenia) are often reported in human
IBD [22].
In dogs, mucosal inflammation is the main histopatho-
logical feature of idiopathic IBD and variants are classi-
cally distinguished regarding their dominant cellular
infiltrates [17,23]. Lymphoplasmacytic enteritis (LPE)
represents the most common form of idiopathic IBD in
dogs [24]. Additionally, eosinophilic gastroenteritis (EGE)
characterised by a mixed infiltration of inflammatory
cells with dominance of eosinophilic granulocytes is the
second most frequently diagnosed form of canine IBD.
Furthermore, several variants of LPE and EGE exist since
inflammation can be restricted to one or more anatomi-
cal sites (e.g. stomach, small intestine, or colon). Addi-
tionally, histiocytic ulcerative colitis (HUC) is a rare
colonic disorder reported in boxers that is characterised
by the histological presence of PAS-positive macrophages
within the colonic mucosa [25,26] that is supposed to be
associated with Escherichia coli [27]. Furthermore, idio-
pathic granulomatous intestinal inflammation charac-
terised by infiltration of macrophages with granuloma
formation similar to CD is rarely reported in dogs
[28,29]. In contrast to human IBD, complications are rare
in canine patients and only thrombocytopenia is dis-
cussed as an extraintestinal manifestation of IBD in dogs
[30]. Although canine idiopathic IBD differs from CD
and UC in humans in several aspects, a common patho-
genesis is suggested. Idiopathic IBD is supposed to
develop in a multilayer model including genetic factors
[31-35], dysregulation of the immune system, and distur-
bances of the intestinal microflora leading to a break-
down of immunological tolerance to luminal antigens
[36,37].
Parasitic infections constitute common intestinal dis-
eases with zoonotic potential in companion animals
[38,39]. Possible clinical signs in dogs include vomiting,
diarrhoea, abdominal pain, and weight loss, but clinical
symptoms may be absent. Histopathologically, affected
tissues reveal varying degrees of cellular infiltrations with
prominence of eosinophilic granulocytes [40] and there-
fore share some histological features with canine idio-
pathic EGE. Immunologically, intestinal helminths trigger
downregulation of the immune system ensuring longer
survival in the host [41,42]. In murine models of nema-
tode infection, Foxp3+ Tregs expand after application of
parasites and correlate with the period of worm survival,
but decrease after application of anti-CD25 antibodies
that is associated with increased intestinal pathology
[43-45]. Furthermore, excretory-secretory products of
several parasites (Heligmosomoides polygyrus, Hae-
monchus contortus,a n dTeladorsagia circumcincta)a r e
known to drive TGF-b-like signalling resulting in expan-
sion of murine Foxp3+ Tregs in vitro and in the gut-
associated lymphoid tissue (GALT) in vivo [46]. Interest-
ingly, the administration of parasitic antigens is discussed
as a possible treatment of human IBD due to their regu-
latory properties [47,48].
Since the availability of specific antibodies, Foxp3 has
been established as a specific marker for Tregs in different
species [49,50] and the literature concerning regulatory T
cells in domestic animals has been increased [51]. In cats,
CD4+ CD25+ Tregs have been characterised in detail in
the context of the pathogenesis of feline immunodefi-
ciency virus [52-55]. Tregs are also described and charac-
terised in pigs [56-58], especially in linkage to foetal
tolerance [59], renal and cardiac allotransplantation
[60-62], and infection with porcine reproductive and
respiratory syndrome virus [63,64]. Expression of Foxp3 is
also reported in cows. Most of bovine Foxp3-positive cells
coexpress CD4 and CD25 [65], although minor popula-
tions of CD8b+a n dgδ+F o x p 3 +Tc e l l sw i t hF o x p 3
expression have been described [66]. However, the regula-
tory properties of CD4+ CD25+ Foxp3+ bovine T cells are
controversially discussed, since gδ+ T cells and CD14+
monocytes but not CD4+ CD25+ Foxp3+ cells exhibited
regulatory function in one study [67]. Additionally, ovine
Foxp3 has recently been described and Foxp3 expressing
cells are significantly increased in the skin of sheep
infected with Psoroptes ovis [68]. Other species in which
Foxp3 expression is described include the horse [69],
baboon [70,71], macaque [72], chimpanzee [73], harbour
seals and walrus [74], and zebrafish [75].
In dogs, the principle of peripheral tolerance was first
suggested in 1976 as a specific population of T cells
seeming to prevent graft-versus-host reaction [76]. In
2007, a subset of CD4+ T cells in blood and/or lymph
nodes of dogs was detected using anti-mouse/rat Foxp3
monoclonal antibodies (clone FJK-16s) and authors sug-
gested crossreactivity of these antibodies with canine
Foxp3 [49]. Since then, the crossreactivity of this anti-
mouse/rat Foxp3 antibody with canine Foxp3 has been
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the canine Foxp3 gene [77]. Additionally to Foxp3, speci-
fic antibodies against canine CD25 have been available
for a few years [77-79] and therefore CD4+ CD25+
Foxp3+ T cells have been described in the canine periph-
eral blood [77,80]. Additionally, canine Foxp3+ Tregs
were investigated in the context of neoplasia, atopic der-
matitis, and adverse food reactions [49,81-87]. Recently,
the regulatory function of canine CD4+ CD25+ Foxp3+
T cells was described in vitro [79,80]. Furthermore, there
is evidence for heterogeneity of canine Tregs since those
with high expression of Foxp3 are possibly activated
Tregs in contrast to Tregs with intermediate expression
of Foxp3, which are suggested to be a more heteroge-
neous population of predominantly activated conven-
tional T cells [80]. Regarding the canine gastrointestinal
tract, there is only one report about the expression of
cytokines and transcription factors of different T cell sub-
sets including Tregs in the duodenum of dogs. In this
study, no alterations in gene expression were present in
dogs with cutaneous food hypersensitivity compared to
healthy controls [86]. Until today, no investigations of
Foxp3 expression in canine idiopathic IBD, nor in canine
nematode infections have been available.
The aim of the study was to investigate the expression
of Foxp3 in the canine GALT in healthy animals and in
dogs with chronic idiopathic IBD. Additionally, we inves-
tigated cases of canine intestinal nematode infections
that share some histopathological features with canine
idiopathic EGE.
Materials and methods
Animals
For the evaluation of Foxp3-positive cells in the normal
canine gut, 18 dogs without gastrointestinal diseases routi-
nely submitted for necropsy to the Institute of Pathology
(University of Veterinary Medicine, Hannover) were used
(Table 1). These dogs were presented to the Small Animal
Clinic of the University of Veterinary Medicine (Hann-
over) because of other problems than gastrointestinal
symptoms. A detailed clinical workup (e.g. case history,
clinical investigation, haematology, serum biochemistry,
ultrasonics, and taking X-rays and MRI if necessary) was
performed by the clinicians on these dogs and no gastroin-
testinal symptoms were present during this procedure.
Additionally, only dogs without any pathomorphological
signs of gastrointestinal disorders during necropsy were
used as healthy controls. Tissue samples collected from
different locations (gastric fundus, descending duodenum,
middle of jejunum, ileum, descending colon, and mesen-
teric lymph node) were taken as soon as possible after
euthanasia (approximately between 15 and 30 minutes
post mortem), being immediately fixed in 10% neutral buf-
fered formalin, and embedded in paraffin. Animals were
grouped as juvenile (0.08 to 0.99 years), middle-aged (1.94
to 6.25 years), and old individuals (8.98 to 15.22 years).
For the investigation of Tregs in canine IBD, gastroin-
testinal biopsy specimen were obtained from 16 dogs suf-
fering from chronic gastrointestinal disorders of
unknown aetiology (ages ranging from 2.00 to 7.22 years)
that were admitted to the Small Animal Clinic of the
University of Veterinary Medicine (Hannover) as well as
to another Small Animal Clinic (Duisburg Asterlagen,
Table 2). Clinically, dogs were presented with chronic (at
least 3 weeks) or recurrent vomiting (no. 1- 4, 6- 8, 13,
1 5 ,a n d1 6 )a n d / o rd i a r r h o e a( n o .1 ,2 ,4 - 1 2 ,1 4 ,a n d1 5 )
partially in conjunction with emaciation (no. 7, 9, 12, 14,
and 16). Detailed clinical workup was performed for
every patient (including clinical examination, taking
X-rays, ultrasonics, haematology, serum biochemistry
comprising determination of cobalamin, urinanalysis,
microbiology and parasitology of faecal samples, and
antimicrobial therapy including application of metronida-
zole). Several endoscopical biopsies (at least four per
localisation) taken from the gastric fundus (n =1 6 ) ,d u o -
denum (n = 16), and colon (n = 8; no. 1, 2, 4, 9, 12, 13,
15, and 16) during routine diagnostics were fixed in 10%
neutral buffered formalin and embedded in paraffin.
Furthermore, 6 dogs with spontaneous intestinal nema-
tode infection detected by macroscopical and/or micro-
scopical findings (age ranges from 0.18 to 1.25 years)
were evaluated (Table 2). Clinically, no gastrointestinal
symptoms were present in these dogs. Fox Terrier dogs
(no. 17 and 18) were euthanised due to progressive para-
paresis and routinely submitted for necropsy to the Insti-
tute of Pathology (University of Veterinary Medicine,
Hannover). Beagle dogs (no. 19-22) were humanely
destroyed for reasons unrelated to the present study fol-
lowed by macroscopical and histopathological examina-
tion. Tissue specimens were taken as soon as possible
after euthanasia (approximately between 15 and 30 min
post mortem) from gastric fundus, descending duode-
num, and descending colon and each were immediately
processed as described above.
Histopathological examination
For histopathological examination, 2-4 μmt h i ns e c t i o n s
were prepared and stained with haematoxylin and eosin
(H&E) by standard histological procedures. Slices were
independently evaluated by 3 pathologists (JJ, US, MHT)
using light microscopes (Carl Zeiss) according to the his-
topathological guidelines for the evaluation and scoring of
canine intestinal inflammation recently published by the
World Small Animal Veterinary Association (WSAVA)
Gastrointestinal Standardisation Group [88]. Concerning
dogs used as healthy controls and dogs with intestinal
nematode infection, only samples with no or minimal
signs of autolysis were included in this study ensuring that
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No. Breed Age (years) Age group WSAVA total WSAVA part Reason for euthanasia
1 Leonberger 0.08 juvenile 1 1 Oesophageal dilatation
2 Labrador 0.20 juvenile 4 2 Oesophageal dilatation
3 Alsatian 0.22 juvenile 0 0 Seizures
4 Pinscher 0.52 juvenile 3 1 Ataxia
5 Briard 0.99 juvenile 0 0 Ataxia
6 Jack Russel Terrier 1.94 middle-aged 3 3 Right hemiparesis
7 Siberian Husky 4.00 middle-aged 6 3 Seizures
8 Kuvasz 4.28 middle-aged 0 0 Vertebral sarcoma
9 Australian Shepherd 4.43 middle-aged 3 3 GME
10 Pointer 5.85 middle-aged 3 0 Hypophyseal adenoma
11 Pyrenean Shepherd 6.09 middle-aged 2 2 Spinal disk herniation
12 Yorkshire Terrier 6.25 middle-aged 4 4 NLE
13 Beagle 8.98 old 4 4 Tonsillar SCC
14 Crossbreed 10.16 old 2 2 GME
15 Crossbreed 12.00 old 4 3 Haemangiosarcoma
16 Alsatian 12.85 old 6 4 Spinal disk herniation
17 Crossbreed 14.77 old 3 2 HCM
18 Crossbreed 15.22 old 1 1 Pancreatic adenocarcinoma
WSAVA = histopathological score regarding the guidelines for evaluation and scoring of canine intestinal inflammation of the World Small Animal Veterinary
Association (WSAVA) Gastrointestinal Standardization Group. WSAVA total = WSAVA score of the total gastrointestinal tract (including stomach, duodenum,
jejunum, ileum, and colon). WSAVA part = WSAVA score of the stomach, duodenum, and colon (for comparison with WSAVA scores of dogs with gastrointestinal
diseases). GME granulomatous meningoencephalitis. NLE necrotizing leucoencephalitis. SCC squamous cell carcinoma. HCM hypertrophic cardiomyopathy.
Table 2 Dogs with inflammatory gastrointestinal diseases.
No. Breed Age (years) Age group WSAVA score Disease
1 Crossbreed 2.00 middle-aged 6 EGE
2 Hungarian Vizslar 2.75 middle-aged 14.5 EGEC
3 Crossbreed 3.00 middle-aged 7 EE
4 Crossbreed 4.60 middle-aged 12 EGEC
5 Border Collie 4.76 middle-aged 5 EE
6 Irish Terrier 7.00 middle-aged 7 EGE
7 Crossbreed 7.00 middle-aged 5.5 EGE
8 Hovawart 2.33 middle-aged 8 LPGEC
9 Malinois 4.00 middle-aged 8.5 LPGE
10 Belgian Shepherd 4.50 middle-aged 7.5 LPGE
11 Jack Russel Terrier 5.24 middle-aged 8 LPGEC
12 Boxer 6.00 middle-aged 9 LPEC
13 Crossbreed 6.50 middle-aged 7.5 LPGE
14 WHWT 6.82 middle-aged 15.5 LPGEC
15 Poodle 7.00 middle-aged 4.5 LPGEC
16 Crossbreed 7.22 middle-aged 4.5 LPGE
17 Fox Terrier 0.18 juvenile 11 NI
18 Fox Terrier 0.18 juvenile 8 NI
19 Beagle 1.17 juvenile 3 NI
20 Beagle 1.17 juvenile 6 NI
21 Beagle 1.25 juvenile 10 NI
22 Beagle 1.25 juvenile 11 NI
WHWT = West Highland White Terrier. EE = IBD, eosinophilic enteritis. EGE = IBD, eosinophilic gastroenteritis. EGEC = IBD, eosinophilic gastroenterocolitis. LPE =
IBD, lymphoplasmacytic enteritis. LPGE = IBD, lymphoplasmacytic gastroenteritis. LPEC = IBD, lymphoplasmacytic enterocolitis. LPGEC = IBD, lymphoplasmacytic
gastroenterocolitis. NI = intestinal nematode infection.
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(Figure 1a-d).
Immunohistochemistry
For immunohistochemistry, 2-4 μmt h i ns e c t i o n sw e r e
dewaxed in Rotihistol (Roth C. GmbH & Co. KG, Karls-
ruhe, Germany) and rehydrated in descending ethanol
series. Blocking of endogenous peroxidase was achieved by
incubation of the sections in H2O2 0.5% in ethanol for
30 min. Antigen retrieval was performed with citrate buf-
fer (pH 6.0, 20 min, 95°C) followed by the application of
normal rabbit serum for 30 min. Sections were then incu-
bated with anti-mouse/rat Foxp3 antibodies (1 in 400
dilution; clone FJK-16s, eBioscience, San Diego, CA) over-
night at 4°C that have shown to detect canine Foxp3 using
flow cytometry [49,77] and immunohistochemistry [89],
followed by secondary antibody application (biotinylated
rabbit anti-rat IgG [H + L]; Vector Laboratories, Burlin-
game, California) for 30 min. Subsequently, avidin-biotin
complex (Vector Laboratories) was utilised for 30 min.
Accordingly, biotinylated tyramine was applied to intensify
the reaction followed by a second incubation with an avi-
din-biotin complex. Between each step, sections were
rinsed three times in phosphate buffered saline (PBS; pH
7.2, 0.15 M). 3,3’-diaminobenzidine and H2O2 was applied
for 5 min to generate a brown colour reaction. Sections
Figure 1 Histology of dogs without gastrointestinal symptoms and of dogs suffering from gastrointestinal diseases. Intestinal samples
of dogs used as healthy controls (A: dog no. 8, bar: 200 μm; B: dog no. 8, bar: 50 μm) and of dogs with intestinal nematode infection (C: dog
no. 20, bar: 200 μm; D: dog no. 20, bar: 50 μm) revealed comparable freshness to intestinal biopsy specimens. In dogs with intestinal nematode
infection, mucosal inflammation was dominated by eosinophilic granulocytes in addition to increased amounts of lymphocytes, plasma cells, and
neutrophils (D: dog no. 20, bar: 50 μm). Furthermore, parasitic structures resembling nematode larvae were occasionally present within
inflammatory foci (E: dog no. 20, bar: 50 μm). In dogs with LPE, intestinal mucosa was infiltrated by lymphocytes and plasma cells (F: dog no. 9,
bar: 100 μm).
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normal canine thymus and mandibular lymph node were
used as positive controls. The primary antibody solution
was substituted with normal rat serum as a negative
control.
Examination of sections
Cells revealing clear lymphocyte morphology with distinct
nuclear staining for Foxp3 but unstained cytoplasm (inter-
preted as Tregs) were quantified in different compartments
(gastric fundus: lamina propria; small intestine: villus, basal
crypt area, villus-crypt junction; large intestine: apical crypt
area, basal crypt area) using a light microscope (Carl Zeiss),
a × 40 objective, a × 10 eyepiece, and a square eyepiece
graticule (10 × 10 squares, with a total area of 62 500 μm
2).
Ten appropriate sites were chosen for each compartment
and arithmetic means were calculated for each one. The
results are expressed as positive cells per 62 500 μm
2.
Statistical analysis
Statistical analyses were performed using R version 2.13.1
(The R Foundation for Statistical Computing, Vienna,
Austria). Primarily, each group was assessed for normal
distribution using a histogram, Q-Q plot, and Shapiro-
Wilk test. Kruskal-Wallis test and/or Wilcoxon rank-sum
test were used to evaluate differences in WSAVA scores
between different age groups in healthy dogs as well as
between dogs with gastrointestinal diseases and controls.
Furthermore, statistical significant differences in the
numbers of Foxp3-positive cells between groups con-
cerning different ages, localisations, and compartments
as well as between diseased dogs and healthy controls
were assessed using the Kruskal-Wallis test and Wil-
c o x o nr a n k - s u mt e s tf o ri n d e p e n d e n ts a m p l e so rt h e
Friedman test and Wilcoxon signed-rank test for related
ones. Furthermore, the Spearman’s rank correlation coef-
ficient was used to investigate the relationship between
intestinal Foxp3-positive cells in dogs with IBD and the
WSAVA score for the appropriate intestinal section.
P values ≤ 0.05 were defined as statistically significant.
Results
Histopathological findings
In dogs lacking clinical and pathomorphological signs of
gastrointestinal diseases, mild histopathological findings
were present in the gut (e.g. mild increases in lamina pro-
pria lymphocytes and plasma cells, crypt abscesses, crypt
dilation, and mucosal fibrosis). These findings are sum-
marised in Table 1 given as WSAVA scores. In these ani-
mals, no significant differences between the WSAVA
scores of different groups of age were present.
Endoscopical biopsy specimens of dogs with chronic or
recurrent gastrointestinal disorders revealed histopathologi-
cal evidence of mucosal inflammation (Figure 1f). Therefore
idiopathic IBD was diagnosed since other possible aetiolo-
gies were excluded (e.g. parasitic disease, bacterial infection,
food allergy, antibiotic-responsive diarrhoea, lymphangiec-
tasia, or neoplasia). Cellular infiltrates were either com-
posed of lymphocytes and plasma cells (n =9 )o rm i x e d
inflammatory cells with prominence of eosinophilic granu-
locytes (n =7 ) .
In dogs with intestinal nematode infection, mucosal
inflammation was dominated by eosinophilic granulocytes
in addition to increased amounts of lymphocytes, plasma
cells, and neutrophils (Figure 1d). Furthermore, parasitic
structures resembling nematode larvae were occasionally
present within inflammatory foci (Figure 1e).
Compared to healthy controls, WSAVA (summarised in
Table 2) were significantly increased in dogs suffering
from IBD (p < 0.001) and in animals with intestinal nema-
tode infections (p < 0.01).
Foxp3 expression in the canine gut of healthy dogs
In healthy dogs, Foxp3 was expressed in both structured
and diffuse parts of the canine GALT. Concerning Peyer’s
patches, Foxp3-positive cells were numerously present in
interfollicular areas and lower amounts were visible in
dome areas (Figure 2a). Only a few cells were located at
the margin of B cell follicles. In gastric lymphoid aggre-
gates as well as in colonic lymphoglandular complexes,
Foxp3-positive cells were randomly distributed around the
follicles. Mesenteric lymph nodes revealed high amounts
of Foxp3-positive Tregs that were largely present in the
paracortex as well as in the medullary sinus. In diffuse
parts of the canine GALT, Foxp3 was expressed by both
lamina propria lymphocytes as well as intraepithelial
lymphocytes.
Numbers of Foxp3 expressing lymphocytes in the gut of
healthy dogs are summarised in Table 3 given as medians
per group. Without consideration of different age groups,
the numbers of lamina propria Foxp3-positive lympho-
cytes were significantly increased in villi compared to
basal crypt areas and the villus-crypt junction (p < 0.001,
Figure 2b and 3a-c) in healthy animals. Furthermore, the
density of Foxp3-positive lymphocytes was significantly
higher in the basal crypt area than in the villus-crypt junc-
tion (p < 0.05). In the colon, Foxp3-expressing cells were
increased in the basal crypt areas compared to the apical
areas (p < 0.05, Figure 3d).
In healthy dogs disregarding their age, villus lamina
propria Foxp3-positive cells were significantly decreased
in the jejunum and the ileum compared to the duodenum
(p < 0.001, Figure 3e). In contrast to this, differences
between the localisations of the small intestine were
neither detected in the basal crypt area nor the villus-
crypt junction.
Furthermore, canine intestinal Tregs revealed differ-
ences in their staining intensity for Foxp3 independent
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weak nuclear staining and some lymphocytes had
strongly labelled nuclei.
Age-related changes in canine intestinal Foxp3
expression
In healthy dogs, the number of villus Foxp3-positive lym-
phocytes were significantly increased in middle-aged
dogs compared to juvenile as well as old animals in the
duodenum and the jejunum (p < 0.05, Figure 3f-h). In the
basal crypt area, an increase in Foxp3-expressing lym-
phocytes was detected in the jejunum between middle-
aged and juvenile dogs (p < 0.05). In the animals exam-
ined, no significant differences in Foxp3 expression
between different age groups were present in the villus-
crypt junction, ileum, gastric fundus, and colonic lamina
propria.
Foxp3 expression in canine gastrointestinal diseases
Numbers of Foxp3 positive intestinal lymphocytes of dogs
with gastrointestinal diseases are summarised in Table 4
given as medians per group. In dogs suffering from IBD,
Foxp3-expressing Tregs of duodenal villi were significantly
decreased in cases with lymphoplasmacytic infiltration
(p < 0.001) and in those predominated by eosinophilic
inflammation (p < 0.01) compared to controls (Figure 4a).
No differences in Foxp3 expression were detected between
cases with lymphoplasmacytic and eosinophilic infiltra-
tions. Indeed, differences in Foxp3 expression between
dogs with IBD and control animals were absent in duode-
nal crypt area, gastric fundus, and colonic lamina propria.
Regarding the Spearman’s rank correlation coefficient,
there was no significant correlation between the number
of Foxp3-expressing lamina propria lymphocytes and the
WSAVA score in the stomach, duodenum, and colon of
dogs with IBD.
In dogs with intestinal nematode infection, Foxp3
expression was significantly increased in the duodenal vil-
lus compared to controls (p < 0.05, Figure 4b). However,
no significant differences in the number of Tregs were
present in the gastric fundus, the duodenal crypt area, and
the colonic mucosa in animals with parasite infections
compared to healthy individuals.
Discussion
Intestinal immune regulation including development of
oral tolerance is of great importance for the maintenance
of gut homeostasis [90]. Concerning this, Tregs occupy a
pivotal role in cell-mediated immunosuppression [5,6].
Therefore, the aim of the study was to investigate the
expression of Foxp3 in canine GALT of healthy and gas-
trointestinal diseased dogs.
Animals lacking clinical and pathomorphological signs
of gastrointestinal diseases were used as healthy controls.
Interestingly, minimal histopathological findings were
Figure 2 Foxp3 expression in the canine healthy GALT.I nc a n i n eP e y e r ’s patches, Foxp3-positive cells were numerously present in
interfollicular areas and lower amounts were visible in dome areas. Only few cells were located at the margin of B cell follicles (A: jejunum, dog
no. 10, bar: 200 μm). Regarding the small intestinal lamina propria, Foxp3-expressing lymphocytes were more numerous in the villus compared
to crypts (B: ileum, dog no. 8, bar: 200 μm, inset bar: 50 μm).
Table 3 Foxp3 expressing lymphocytes in dogs without
gastrointestinal diseases.
Localisation Compartment Total Juvenile Middle-aged Old
stomach la pro 1.13 0.60 1.31 0.98
duodenum vi 10.67 3.50 18.92 9.56
duodenum cry-b 2.49 0.50 2.33 3.14
duodenum jun 1.31 1.20 2.06 1.00
duodenum cry-total 1.89 0.85 2.85 1.95
jejunum vi 6.45 2.18 13.13 3.53
jejunum cry-b 1.78 0.54 2.29 2.05
jejunum jun 1.26 1.27 1.46 1.00
ileum vi 4.61 4.00 8.54 3.53
ileum cry-b 2.62 0.93 2.88 2.89
ileum jun 1.96 1.36 2.50 1.96
colon cry-a 0.80 0.25 1.10 0.80
colon cry-b 1.95 0.66 2.00 1.98
Medians of Foxp3+ lymphocytes per group are given as cells/62 500 μm
2.
Total = all dogs disregarding their age. la pro = lamina propria. vi = villus. cry-
b = basal crypt area. jun = villus-crypt junction. cry-total = total crypt area.
cry-a = apical crypt area.
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Figure 3 Intestinal Foxp3 expression in dogs without gastrointestinal diseases. Without consideration of their age, numbers of lamina
propria Foxp3-positive lymphocytes were significantly increased in the villus compared to the basal crypt area as well as the villus-crypt junction
and the density of Foxp3-positive lymphocytes was significantly higher in the basal crypt area than in the villus-crypt junction (A-C). In the colon,
Foxp3-positive cells were increased in the basal crypt area compared to the apical part (D). Regarding the villus, lamina propria Foxp3-positive
cells were significantly decreased in the jejunum and the ileum compared to the duodenum in healthy dogs disregarding their age (E).
Concerning age-related changes, numbers of villus Foxp3-positive lymphocytes were significantly increased in middle-aged dogs compared to
juvenile as well as old animals in the duodenum and the jejunum (F-G). In contrast, age-related changes were absent in the ileum (H). vi = villus.
cry-b = basal crypt area. jun = villus-crypt junction. cry-a = apical crypt area. duo = duodenum. jej = jejunum. ile = Ileum. 1 = juvenile. 2 =
middle-aged. 3 = old. * = p < 0.05. *** = p < 0.001.
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Page 8 of 14present in the gastrointestinal tract of these dogs. Due to
the absence of clinical and morphological correlates,
these findings were interpreted as background variances
of the canine gut. Although several reports on age-related
changes and immunosenescence in dogs [91] would sug-
gest an increasing inflammatory background in the
canine elderly, no differences between the WSAVA
scores of different age groups were observed. In contrast,
WSAVA scores were significantly increased in dogs with
gastrointestinal diseases compared to controls.
Immunohistochemically, application of anti-Foxp3
antibodies produced clear nuclear staining of cells reveal-
ing distinct lymphocyte morphology. Although Foxp3
has been established as a specific marker for classical
Tregs further characterised by the expression of CD4 and
CD25, heterogeneity of this cell population has been
described [92]. In dogs, recent analyses on canine Tregs
illustrate CD4-positive cells with intermediate Foxp3
expression and authors postulate that they are activated
heterogeneous conventional T cells instead of Tregs [80].
In our study, differences in staining intensity for Foxp3
were noticed immunohistochemically. This suggests
differences in Foxp3 expression in situ supporting the
concept of canine Treg heterogeneity. However, this
result could also be due to the localisation of Tregs in
different tissue layers and needs to be further
investigated.
Structured lymphoid tissue in the intestine plays a cru-
cial role in mucosal immunology especially in induction
and gut homing of intestinal Tregs and therefore for the
establishment of oral tolerance [13,93]. The high density
of Foxp3-expressing lymphocytes in those areas suggests
similar roles of these anatomical compartments in dogs.
Additionally, Foxp3 was expressed by intraepithelial
lymphocytes (IEL). It is well established that canine IEL
are mainly characterised by the expression of CD8. How-
ever, less than 15 percent of these cells are CD4-positive
[94]. Although most canine Tregs are known to express
CD4, CD25, and Foxp3, a minor subpopulation of CD8-
positive lymphocytes with strong Foxp3 expression is
described [80]. In spite of their correct phenotype, our
results confirm the immunoregulatory phenotype of
canine IEL, which has recently been observed in vitro
[94].
Furthermore, Foxp3-positive lymphocytes were present
in the lamina propria. Concerning different compart-
ments (vertical distribution), Tregs were significantly
increased in the villus lamina propria compared to basal
crypt area and villus-crypt junction. Previous studies
about intestinal T cells in dogs report similar differences
in their distribution [95-97]. Referring to this, a stronger
exposition of the intestinal apical surface to luminal anti-
gens is discussed. Analogously, increasing numbers of
Tregs in the villus area may be related to the great
importance of immunoregulation in areas characterised
by high antigenic load, antigen sampling by dendritic
cells, and priming of immune responses.
Table 4 Foxp3 expressing lymphocytes in dogs suffering
from gastrointestinal diseases.
Localisation Compartment IBD total IBD-E IBD-LP Nematode
stomach la pro 0.85 1.00 0.70 1.90
duodenum vi 4.13 4.37 1.85 21.06
duodenum cry-total 1.41 1.81 0.57 3.16
colon cry-a 1.63 2.38 1.50 2.02
colon cry-b 2.81 3.00 1.60 1.86
Medians of Foxp3+ lymphocytes per group are given as cells/62 500 μm
2.l a
pro = lamina propria. vi = villus. cry-total = total crypt area. cry-a = apical
crypt area. cry-b = basal crypt area. IBD-E = IBD dominated by eosinophilic
inflammation. IBD-LP = IBD characterised by lymphoplasmacytic infiltration.
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Figure 4 Intestinal Foxp3 expression in dogs suffering from gastrointestinal diseases. In canine IBD (age ranged from 2.00 to 7.22 years),
Foxp3-positive cells of the duodenal villus were significantly decreased in cases with lymphoplasmacytic infiltration and in those predominated
by eosinophilic inflammation compared to middle-aged controls (A). In dogs with spontaneous intestinal nematode infection (age ranged from
0.18 to 1.25 years), Foxp3 expression was significantly increased in the duodenal villus compared to juvenile healthy animals (B). E = IBD
dominated by eosinophilic inflammation. LP = IBD characterised by lymphoplasmacytic infiltration. * = p < 0.05. ** = p < 0.01. *** = p < 0.001.
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Page 9 of 14Additionally, the numbers of Foxp3-positive cells were
significantly higher in the basal crypt area than in the vil-
lus-crypt junction. This finding was in contrast to pre-
vious observations of a constant increase in CD3-positive
cells towards the villus tip [95-97]. Possibly, the increase
in Tregs in the basal crypt area compared to the villus-
crypt junction is due to increased numbers of IgA-secret-
ing plasma cells towards the crypt [96] requiring a more
intense local tuning of immunological tolerance in basal
areas.
Interestingly, a vertical decline in Tregs was found in the
colonic mucosa since the numbers of Foxp3-positive lym-
phocytes were significantly lower in the apical crypt area
than in the basal part. Potentially, this is related to general
differences of colonic Tregs in comparison to those
located in the small intestine highlighting the heterogene-
ity of regulatory T cells. Otherwise, these differences may
be due to the individual anatomy and physiology of the
small and large intestines. However, further studies are
needed to confirm possible differences in the vertical dis-
tribution of lymphocytes in the colonic mucosa and to
evaluate its relevance.
Concerning the horizontal distribution of Tregs along the
small intestinal villus, numbers of Foxp3-positive lympho-
cytes were significantly decreased from duodenal to jejunal
as well as to ileal mucosa. In contrast to this, no horizontal
differences in the expression of CD3, CD4, or CD8 have
been reported [95,97]. The horizontal decline in expression
of Foxp3 may be explained by decreasing amounts of food
antigens progressively destroyed along the small intestine,
although the numbers of bacteria progressively increase
from the duodenum to the large bowel [98]. Regarding the
lower frequencies of Tregs at the luminal site of the colonic
mucosa compared to those in the small intestine, it is possi-
ble that food proteins are more potent generators of intest-
inal Tregs than commensal bacteria. In mice, it has recently
been shown that T cell receptors of colonic Tregs differ
from those used by Tregs in other locations [99]. Therefore,
canine colonic Tregs may generally differ from those in
other areas including the small intestine.
In healthy dogs, age-related changes in Foxp3 expres-
sion were observed since Tregs increased in middle-aged
animals compared to juvenile as well as older individuals.
Age-dependent alterations of the immune system are
well-known in companion animals [91,100] and several
reports on alterations of the canine gastrointestinal tract
concerning different age groups exist [97,101,102]. For
instance, intestinal lamina propria CD3-positive T cells
and macrophages decline in older animals, whereas IgA-
containing plasma cells increase with age [97]. Although
age-related differences in Tregs are controversially dis-
cussed [103] and only age groups with small numbers of
animals (5 to 7 dogs per age group) were examined in
this study, our data suggest an increase of intestinal
Tregs in middle-age dogs that may be an indication for
an increase of oral tolerance in these dogs compared to
juvenile individuals. Nevertheless, the numbers of Tregs
m a yc h a n g ei nt h ec a n i n eg u td u r i n gt h ef i r s ty e a ro fl i f e
s i n c et h ec a n i n ei m m u n es y s t e mi n c l u d i n gt h eG A L T
undergoes maturation during this period. Additionally,
the decline in Foxp3 expression in old animals could be a
sign of immunosenescence and could possibly mean a
loss of oral tolerance in the canine elderly.
Although age-related changes in Foxp3 expression were
of statistical significance in this study, further investiga-
tions are needed to confirm these results using higher
numbers of animals and to check the course of Tregs in
juvenile dogs.
Dysregulation of mucosal immunology including a fail-
ure of oral tolerance against commensal bacteria and food
proteins seems to play a crucial role in the pathogenesis of
both human and canine IBD [36,104]. As it is already
known, depletion of regulatory T cells leads to chronic
colitis in immunodeficient mice [11]. Furthermore, intra-
venous application of Tregs can cure established intestinal
inflammation in animal models for experimental colitis
[105,106]. In Long-Evans Cinnamon rats (deficient in thy-
mocyte development) showing spontaneous development
of IBD-like colitis, Tregs are significantly reduced in the
colonic lamina propria [9]. Interestingly, Foxp3-positive
Tregs are present at higher densities in the lamina propria
of human patients suffering from IBD than in healthy con-
trols [107-109]. This indicates an impaired function of
Tregs or a resistance of T effector cells to Treg-mediated
suppression instead of a numerical aberrance in the Treg
population. However, investigated dogs suffering form
IBD revealed a significant reduction of Foxp3 expression
in the duodenal villi in cases of both eosinophilic and lym-
phoplasmacytic inflammation compared to controls.
Further studies using full-thickness intestinal samples are
needed to check if similar differences in Tregs are also
present in the jejunum and ileum in canine IBD. Interest-
ingly, no differences in Treg numbers were present in the
stomach and colon of dogs with IBD in comparison to
controls. This may be an indication of different roles of
small intestinal Tregs compared to those located in the
stomach and the colon for canine IBD. Under physiologi-
cal conditions, enrichment of Tregs in areas of inflamma-
tion is mediated by a negative feedback mechanism via
IL-2 produced by T effector cells ensuring a balanced
cooperation between protective immune responses and
immunosuppression [110]. Therefore, our results may be a
sign of a primary defect in Treg homeostasis leading to
chronic inflammation due to a lack of immune regulation
as a pathogenetic factor in canine IBD. Further studies on
Treg function are needed to confirm this possibility.
Unlike dogs with IBD, dogs with intestinal nematode
infection revealed increased numbers of Tregs in the
Junginger et al. Veterinary Research 2012, 43:23
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Page 10 of 14duodenal villus compared to controls. Interestingly, no
differences in Treg numbers were present in the sto-
mach and colon of dogs with nematode infection in
comparison to controls. Therefore, further studies are
needed to determine whether this is related to the
nematode species and its localisation in the gut or due
to general differences in canine Tregs in the small intes-
tine compared to those located in the stomach and
colon. Intestinal parasites are known to trigger Th2
dominated immune responses and cause down regula-
tion of immune responses ensuring a better survival in
their hosts [42,111]. Particularly, suspension of Treg
activity leads to exacerbated intestinal pathology and
enhances parasite clearance [43,44]. Furthermore, hel-
minth secretions are able to induce Foxp3 expression
and enhance the regulatory function of T cells [46].
Therefore, our results suggest a parasite-related increase
in intestinal immune regulation, although IL-2 mediated
enrichment of Tregs may also be involved. Interestingly,
parasites are discussed as potential strategies for the
treatment of human IBD due to their ability to prevent
intestinal pathology and their immunoregulatory proper-
ties [47,48].
This study elucidates that regulatory T cells are
expressed in the canine GALT with a decline of Tregs
from the villus to the crypt and age-related changes sug-
gesting a progressive establishment of oral tolerance and
immunosenescence including decreased oral tolerance in
the canine elderly. A reduced number of Tregs in canine
IBD suggests a defect in Treg homeostasis leading to a
loss of oral tolerance. In addition, Tregs were enriched in
the duodenal villi of dogs with intestinal nematode infec-
tion indicating a parasite-induced enhancement of intest-
inal immune regulation.
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